Nearly 1 in 5 U.S. counties lacked opioid treatment programs or any office-based providers of buprenorphine, which reduces the risk of future overdoses, according to a federal review of whether drugs for opioid abuse are reaching areas of greatest need. n 2022, individuals seeking treatment — including those enrolled in Medicare or Medicaid — often face hurdles finding providers allowed to prescribe and dispense drugs for opioid use disorder, the Department of Health and Human Services inspector general’s review found. Medicare Advantage prior authorization requirements, low Medicaid reimbursement rates and inadequate public information about provider locations all contribute to the barriers, per the review.
Read the full article: Opioid Abuse Treatments Don’t Reach Areas Most in Need //
Source: https://www.axios.com/2024/09/24/opioid-abuse-treatments-barriers